跳至主要内容
临床试验/DRKS00003929
DRKS00003929招募中不适用

Prospective data acquisition of diagnosis, treatment and course of disease in adult acute lymphoblastic leukemia (ALL) and related diseases in conjunction with a prospective collection of biomaterial - ALL GMALL Register

GMALL-Studiengruppe0 个研究点目标入组 500 人开始时间: 2014年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • # Age min . 18 years
  • # Written informed consent
  • # Therapy analogous to a GMALL therapy optimization study or GMALL therapy recommendation
  • # One of the following three inclusion criteria :
  • # 1 acute lymphoblastic leukemia
  • # 2 other leukemias (NK-cell lymphoma / leukemia or acute biphenotypic leukemia)
  • # 3. Non-Hodgkin's lymphoma following subtypes ( WHO classification ) : Burkitt 's lymphoma (incl. Atypical Burkitt 's lymphoma, Burkitt-like lymphoma ) , diffuse large B-cell lymphoma ( DLBCL particular primary mediastinal , DLBCL with Burkitt -Signature , C-myc-positive DLBCL ), B-cell lymphoblastic lymphoma, T-cell lymphoblastic lymphoma, Large Cell Anaplastic lymphoma, NHL Other

排除标准

  • 未提供

研究者

发起方
GMALL-Studiengruppe

相似试验

Prospective data acquisition of diagnosis, treatment... | 临床试验